Source: Annual Congress 2006 - Cystic fibrosis lung disease: infection, inflammation or both?
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. E. Bock, B. H. Knöpfli, G. Schnetzler (Davos Platz, Zurich, Switzerland). Scedosporium induced deterioration and treatment in juvenile cystic fibrosis. Eur Respir J 2006; 28: Suppl. 50, 2801

Member's Comments

No comment yet.

Related content which might interest you: Temporal progression of fungal microbiota in patients with cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015 Cystic fibrosis Source: Respipedia Article Year: 2018 Emerging pathogens in cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=66 Year: 2006 Early renal involvement in children with cystic fibrosis. Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Scedosporium species (Sspp) in patients with cystic fibrosis (CF): Implications for clinical practice Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage Source: Eur Respir J 2003; 22: Suppl. 45, 504s Year: 2003 Late presenting cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis: no longer just kids‘ stuff Year: 2005 The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021 The ageing cystic fibrosis patient Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients Year: 2018 Ectopic subpleural fat deposition in idiopathic pulmonary fibrosis correlates with radiographic extension of fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017 Year: 2018 Neomacrolides in cystic fibrosis Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012 The spectrum of Nocardia lung disease in cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Massive hemoptysis in cystic fibrosis adult patients Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Fungal plug caused segmental atelectasis in a patient with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 498s Year: 2006 Pirfenidone in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 35: 821-829 Year: 2010 Pirfenidone in idiopathic pulmonary fibrosis Source: Eur Respir J 2010; 36: 695-696 Year: 2010 Antibiotic treatment of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 188-202 Year: 2014